Zoledronic Acid

8 trials 4 recruiting MMusculoskeletal

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

8 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 2 Phase II: 2 Phase III/IV: 3 Phase IV: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Chronic recurrent multifocal osteomyelitis 1 Osteogenesis imperfecta 1

Sponsors using this IMP

Aarhus University Hospital 2 Oslo University Hospital HF 2 Assistance Publique Hopitaux De Paris 1 AUVA Trauma Center Vienna 1 Region Midtjylland 1 Ultragenyx Pharmaceutical Inc. 1

All trials

8 total

Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis r… Pending

2023-506420-93-00 Phase II 1 country Assistance Publique Hopitaux De Paris
ZAMBA: Zoledronic Acid for Modic Back Pain. Pending

2024-517345-14-00 Phase III 1 country Oslo University Hospital HF
Influence Of Zoledronic Acid On Healing After Arthroskopic Repair Of Chronic Rotator Cuff Lesions A Prospective, Randomized, Placebo-Control… Pending

2024-519082-22-00 Phase II 1 country AUVA Trauma Center Vienna
Setrusumab vs Bisphosphonates in Pediatric Subjects with Osteogenesis Imperfecta (Cosmic) Recruiting

2023-504196-24-00 Phase III 5 countries Ultragenyx Pharmaceutical Inc.
Bisphosphonate vs. Placebo Prior to Parathyroidectomy in Primary Hyperparathyroidisme: A Randomized, blinded Placebo-controlled Trial Recruiting

2024-520073-13-00 Phase III/IV 1 country Region Midtjylland
The OPTIMIST study Recruiting

2023-505940-20-00 Phase III/IV 1 country Aarhus University Hospital
Treatment with zoledronate subsequent to denosumab in osteoporosis 2 Recruiting

2022-502621-17-00 Phase III/IV 1 country Aarhus University Hospital
Zoledronate Early to Hip Fractures Patients – safe and effective? A Randomized controlled double-blinded treatment strategy trial on Zoledro… Ended

2023-510198-32-00 Phase IV 1 country Oslo University Hospital HF

Showing 1–8 of 8 trials

← All drugs A–Z